Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 26 | 25 | 16 | 45 | 35 |
| Cost of Goods | 68 | 10 | 10 | 7 | 8 |
| Gross Profit | -42 | 15 | 6 | 38 | 27 |
| Operating Expenses | 2,473 | 2,671 | 3,635 | 5,900 | 4,524 |
| Operating Income | -2,447 | -2,646 | -3,619 | -5,855 | -4,489 |
| Interest Expense | 148 | 149 | 124 | 132 | 202 |
| Other Income | -689 | 1 | 38 | 20 | 991 |
| Pre-tax Income | -3,284 | -2,794 | -3,705 | -5,967 | -3,700 |
| Net Income Continuous | -3,284 | -2,794 | -3,705 | -5,967 | -3,700 |
| Net Income | $-3,284 | $-2,794 | $-3,705 | $-5,967 | $-3,700 |
| EPS Basic Total Ops | -1.57 | -3.68 | -5.00 | -10.00 | -6.00 |
| EPS Basic Continuous Ops | -1.57 | -3.68 | -5.27 | -9.27 | -6.42 |
| EPS Diluted Total Ops | -1.57 | -3.68 | -5.00 | -10.00 | -6.00 |
| EPS Diluted Continuous Ops | -1.57 | -3.68 | -5.27 | -9.27 | -6.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.68 | -5.00 | -10.00 | -6.00 |
| EBITDA(a) | $-2,242 | $-2,192 | $-3,162 | $-5,720 | $-4,418 |